Melatonin protects nigral dopaminergic neurons from 1-methyl-4- phenylpyridinium (MPP+) neurotoxicity in rats

Neuroscience Letters

Volumn 245, Issue 2, 1998, Pages 61-64

  Jin, Byung K ^a   Shin, Dong Y ^a   Jeong, Mi Y ^a   Gwag, Mi R ^a   Baik, Haing W ^a   Yoon, Kyung S ^a   Cho, Yong H ^a   Joo, Wan S ^b   Kim, Yong S ^b   Baik, Hyung H ^a  

^a Kyung Hee University Hospital   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

1 methyl 4 phenylpiridinium; Malondialdehyde; Melatonin; Oxidative stress; Parkinson's disease; Striatum; Substantia nigra; Tyrosine hydroxylase

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; MELATONIN;

ANIMAL EXPERIMENT; ARTICLE; DRUG EFFECT; LIPID PEROXIDATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

1-METHYL-4-PHENYLPYRIDINIUM; ANIMALS; ANTIOXIDANTS; DOPAMINE; DOPAMINE AGENTS; FEMALE; MALE; MELATONIN; NEURONS; PARKINSON DISEASE; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA;

EID: 0032478554     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(98)00170-0     Document Type: Article

References (29)

1. Acuna-Castroviejo D., Coto-Momtes A., Gaia Monti M., Oritz G.G., Reiter R.J. Melatonin is protective against MPTP-induced striatal and hippocampal lesions. Life Sci. 60:1997;23-29.
2. + neurotoxicity against rat dopaminergic neurons in culture. Neurosci. Lett. 193(1):1995;53-56.
3. + toxicity in rat striatal slices: relationship between non-selective effects and free radical production. Neurochem. Res. 21(1):1996;73-78.
4. Antolin I., Rodriguez C., Sainz R.M., Mayo J.C., Uria H., Kotler M.L., Rodriguez-Colunga M.J., Tolivia D., Menendez-Pelaez A. Neurohormone melatonin prevents cell damage: effect on gene expression for antioxidant enzymes. FASEB J. 10:1996;882-890.
5. Bradbury A.J., Costall B., Domeney A.M., Jenner P., Kelly M.E., Marsden C.D., Naylor R.J. 1-Methyl-4-phenylpyridine is neurotoxic to the nigrostriatal dopamine pathway. Nature. 319:1986;56-57.
6. Cagnoli C.M., Atabay C., Kharlamov E., Manev H. Melatonin protects neurons from singlet oxygen-induced apoptosis. J. Pineal Res. 8:1995;222-226.
7. Cho S.H., Joh T.H., Baik H.H., Dibinis C., Volpe B.T. Melatonin administration protects CA1 hippocampal neurons after transient forebrain ischemia in rats. Brain Res. 755:1997;335-338.
8. Coyle J.T., Puttfarken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science. 262:1993;689-694.
9. +. J. Neurosci. 13(7):1993;3104-3111.
10. + produces progressive neuronal degeneration which is mediated by oxidative stress. Exp. Neurol. 144:1997;193-198.
11. Giusti P., Lipartiti M., Franchceschini D., Schiavo N., Floreani M., Manev H. Neuroprotection by melatonin from kainate-induced excitotoxicity in rats. FASEB J. 10:1996;891-896.
12. Goldman, BD., The physiology of melatonin in mammals. In R.J. Reiter (Ed.), Pineal Research Review, Liss, New York, 1983, pp. 145-182.
13. Gotz M.E., Kunig G., Riederer P., Youdium M.B.H. Oxidative stress: free radical production in neural degeneration. Pharmacol. Ther. 63:1994;37-122.
14. Hirsch E.C. Does oxidative stress participate in nerve cell death in Parkinson's disease. Eur. Neurol. 33(Suppl. 1):1993;52-59.
15. Jin B.K., Iacovitti L. Dopamine differentiation factors produce partial motor recovery in 6-hydroxydopamine lesioned rats. Neurobiol. Dis. 2:1995;1-12.
16. Jin B.K., Iacovitti L. Dopamine differentiation factors increase striatal dopaminergic function in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine lesioned mice. J. Neurosci. Res. 43:1996;331-334.
17. Langston, J.W., The etiology of Parkinson's disease, new directions for research. In J. Jankovic and E. Tolosa (Ed.), Parkinson's Disease and Movement Disorders, Urban and Schwarzenberg, Baltimore, MD, 1988, pp. 75-85.
18. Melchiorri D., Reiter R.J., Attia A.M., Hara M., Nistico G. Potent protective effect of melatonin on in vivo paraquat-induced oxidative damage in rats. Life Sci. 56:1995;83-89.
19. Ohkawa H., Nobuko O., Yaoh K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95:1979;351-358.
20. Olanow C.W. A radical hypothesis for neurodegeneration. Trends Neurosci. 16:1993;439-444.
21. Paxinos, G. and Watson, C., The Rat Brain in Stereotaxic Coordinates (2nd edn.), Academic Press, New York, 1986.
22. Pierrefiche G., Topall G., Courbain G., Henriet I., Laborit H. Antioxidant activity of melatonin in mice. Res. Commun. Chem. Pathol. Pharmacol. 80:1993;211-223.
23. Reiter R.J., Tan D.X., Poeggeler B., Menendez-Pelaez A., Chen L.D., Saarela S. Melatonin is a free radical scavenger: implication of aging and age-related disease. Ann. N. Y. Acad. Sci. 719:1994;1-12.
24. Reiter R., Tang L., Garcia J.J., Munoz-Hoyos A. Pharmacological actions of melatonin in oxygen radical pathophysiology. Life Sci. 60:1997;2255-2271.
25. Spina M.B., Squinto S.P., Miller J., Lindsay R.M., Hyman C. Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: involvement of the glutathione system. J. Neurochem. 59(1):1992;99-106.
26. Storey E., Hyman B.T., Jenkis B., Brouillet E., Miller J.M., Rosen B.R., Beal M.F. 1-Methyl-4-phenylpyridinium produces excitotoxic lesions in the rat striatum as a result of impairment of oxidative metabolism. J. Neurochem. 58:1992;1975-1978.
27. Tan D.X., Chen L.D., Poeggeler B., Manchester L.C., Reiter R.J. Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocrine J. 1:1993;57-60.
28. + neurotoxicity by N-methyl-D-aspartate antagonists. Nature. 349:1991;414-418.
29. 14C-melatonin in rat: a biochemical and autoradiographic study. J. Pineal Res. 5:1988;437-453.